Fahreignung und Fahrsicherheit bei Epilepsie: Grundlagen, neue Leitlinien und Kommentar

[Driving ability with cerebral perfusion disorders]

In Germany expert testimony on driving ability requires knowledge of the corresponding legislation, the guidelines for expertises on driver aptitude and a qualification in traffic medicine. The testimony should clearly identify handicaps with regard to driving, give estimates on the risks of a sudden loss of the driving capability by stroke recurrence or epileptic seizures, and also consider personal attitudes, such as inadequate behaviour and lack of insight. Physical handicaps can often be compensated for by restraints, such as vehicle modifications and restrictions, such as daylight driving only.The testimony must also give estimates on the risks of a sudden loss of the driving capability by stroke recurrence or epileptic seizures. Two models are proposed by which an estimate of harmful traffic accidents due to stroke recurrence can be made.

[Assessment of driving in patients with vertigo and dizziness]

The driving performance of patients with dizziness and vertigo has gained only minor attention so far. Patients with permanent vestibular loss or with episodic vestibular symptoms can experience difficulties in driving a motor vehicle. The presence of a chronic or episodic syndrome presenting with dizziness and/or vertigo does not automatically exclude the ability to drive. Assessment of driving performance should consider the degree of the deficits and compensation in chronic dysfunction and the severity and frequency of attacks, prodromes and triggers of symptoms in episodic disorders.

Epilepsy and driving: considerations on how eligibility should be decided

Although few neurologists are formally trained in traffic medicine, they are frequently asked to assess whether a patient is medically fit to drive. For patients with epilepsy, the physician must assess the risk of the patient having a seizure while driving, and decide what is an acceptable risk. The legislation on this subject is aiming at finding a reasonable balance between two important considerations: public safety and a patient's individual need to drive. For the neurologist to explain and put into practice the legislation may be a demanding task and a challenge to the doctor-patient alliance. The decision on driving capability should be tailored to the individual patient and based on careful evaluation and informed judgement. In Norway, to qualify for a driver's license, a seizure-free interval of at least 12 months is currently required for group 1 drivers (passenger cars), whereas group 2 drivers (heavy motor vehicles, commercial driving) must have been seizure-free for at least 10 years and not have experienced epileptic seizures from the age of 18 years. Norwegian physicians are obliged to report patients with seizures to driving authorities, although this is an unpopular rule. In reviewing the available literature, it is apparent that despite there being relatively few sound studies, the risks of car accidents among persons with epilepsy may previously have been overestimated.